Science ❯ Medicine

Clinical Trials

Drug Development Cancer Treatment Trials Double-Blinded Randomized Clinical Trials Phase 3 Studies Patient Safety Phase III Clinical Trials Phase III Trials Phase 2 Clinical Trials Drug Safety Drug Efficacy

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

The rare-disease specialist moves to add a Phase 3 hepatitis D antibody ahead of a 2026 efficacy readout.

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

FDA Flags Possible License Revocation for Sarepta’s Elevidys